BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 104 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $584,000 | -15.4% | 188,773 | -1.2% | 0.02% | -18.2% |
| Q3 2021 | $690,000 | +0.1% | 191,100 | -0.7% | 0.02% | -4.3% |
| Q2 2021 | $689,000 | -8.4% | 192,400 | 0.0% | 0.02% | -14.8% |
| Q1 2021 | $752,000 | -1.4% | 192,400 | +5.9% | 0.03% | +3.8% |
| Q4 2020 | $763,000 | +11.1% | 181,600 | -1.4% | 0.03% | +18.2% |
| Q3 2020 | $687,000 | -38.7% | 184,200 | -28.4% | 0.02% | -29.0% |
| Q2 2020 | $1,120,000 | -10.5% | 257,087 | -22.2% | 0.03% | -16.2% |
| Q1 2020 | $1,252,000 | -51.2% | 330,399 | -18.6% | 0.04% | -37.3% |
| Q4 2019 | $2,567,000 | +32.9% | 406,099 | -11.5% | 0.06% | +37.2% |
| Q3 2019 | $1,932,000 | +27.9% | 458,999 | +41.3% | 0.04% | +26.5% |
| Q2 2019 | $1,510,000 | -41.3% | 324,888 | -33.0% | 0.03% | -34.6% |
| Q1 2019 | $2,571,000 | – | 485,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |